ZEST trial fails to meet enrollment goals for ctDNA testing in breast cancer
The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating ...
The ZEST clinical trial, designed to evaluate niraparib (Zejula) for the prevention of breast cancer recurrence in patients with circulating ...
Prostate cancer hijacks the normal prostate's growth regulation program to release the brakes and grow freely, according to Weill Cornell ...
Researchers are shining a light on cancer cells' energy centers – literally – to damage these power sources and trigger ...
Lupus causes chronic pain, fatigue, and potentially organ damage for 1.5 million Americans and is a challenge for researchers trying to ...
Several rare immune disorders are caused by mutations in the patient's DNA. The University of Surrey and its collaborators found ...
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria. When ...
New research from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that one's biological ...
Researchers at Kyushu University have revealed how spatial distance between specific regions of DNA is linked to bursts of gene ...
Analysis of cheek swabs taken from pregnant women revealed a potential epigenetic biomarker for preeclampsia, a potentially life-threatening condition that ...
Certain intestinal bacteria are found more frequently in countries such as Norway than in a number of other countries and ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net